2 Fast-Growing Pharmaceutical Stocks to Buy Now
(NASDAQ: INCY) and TG Therapeutics (NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for its work in Janus kinase (JAK) inhibition, focusing on dermatology, oncology, hematology, inflammation, and autoimmune disorders.TG Therapeutics is focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases.
Both stocks are delivering strong returns. Shares of Incyte are up more than 17% this year, while TG Therapeutics is up nearly 90% so far in 2026.
Here are reasons to buy the pharmaceutical stocks:
Source Fool.com
Incyte Corp. Aktie
104,90 €
-0,62 %
Incyte Corp. erfreut sich großer Beliebtheit, mit einer hohen Zahl an Buy- und niedriger Zahl an Sell-Einschätzungen.
Ein leichtes Potenzial nach oben für Incyte Corp. mit einem Kursziel von 114 € gegenüber dem aktuellen Kurs von 104.9 €.
